Patent Technology for Skin Absorption... No.1 Antifungal Medicine

Dong-A Pharmaceutical 'Tervine Gel'

[Asia Economy Reporter Seo So-jung] Dong-A Pharmaceutical's 'Tervineugel' is an easily purchasable antifungal treatment available at pharmacies.

According to the pharmaceutical market research firm UBIST, Tervineugel ranked first in sales volume among over-the-counter antifungal medications in South Korea last year. Until now, the domestic over-the-counter antifungal market had long been dominated by multinational pharmaceutical companies, but Tervineugel broke that trend.

Tervineugel utilizes Dong-A Pharmaceutical's patented technology that forms a film layer upon application, aiding the skin absorption of the drug, thereby improving absorption and durability. Its high absorption and lasting effect demonstrate excellent efficacy even against hyperkeratotic athlete's foot, where drug absorption is difficult due to thickened stratum corneum.

It also enhances consumer convenience. As a gel type, it absorbs quickly and dries within approximately 2 to 3 minutes, providing a refreshing sensation upon use. It significantly reduces the inconvenience of having sticky feet that leave footprints on the floor after application.

Following the launch of 'TervineuOnce,' a single-application product, in 2018, Dong-A Pharmaceutical released 'TervineuDouble Action Gel' last year, which contains a complex ingredient to relieve itching.

Last year, the sales volume of Tervineugel was about 1 million units, meaning one unit was sold every 15 seconds at pharmacies. All three products?Tervineugel, TervineuOnce, and TervineuDouble Action Gel?are available for purchase at pharmacies.

This content was produced with the assistance of AI translation services.